IL75903A - Di-isopropyl ether solvates of beclomethasone 17,21-dipropionate,their preparation and use - Google Patents
Di-isopropyl ether solvates of beclomethasone 17,21-dipropionate,their preparation and useInfo
- Publication number
- IL75903A IL75903A IL8575903A IL7590385A IL75903A IL 75903 A IL75903 A IL 75903A IL 8575903 A IL8575903 A IL 8575903A IL 7590385 A IL7590385 A IL 7590385A IL 75903 A IL75903 A IL 75903A
- Authority
- IL
- Israel
- Prior art keywords
- beclomethasone
- dipropionate
- preparation
- isopropyl ether
- ether solvates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pulmonology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Glass Compositions (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PT7897284A PT78972A (en) | 1984-07-25 | 1984-07-25 | Preparation process of a 17,21-dipropionate beclomethasona di-isopropylic ether solution and its utilization |
PT8079685A PT80796B (pt) | 1985-07-11 | 1985-07-11 | Processo para a preparacao de solvatos etoericos de beclometasona 17,21-dipropionato e utilizacao dos mesmos |
Publications (2)
Publication Number | Publication Date |
---|---|
IL75903A0 IL75903A0 (en) | 1985-12-31 |
IL75903A true IL75903A (en) | 1989-10-31 |
Family
ID=26653439
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL8575903A IL75903A (en) | 1984-07-25 | 1985-07-24 | Di-isopropyl ether solvates of beclomethasone 17,21-dipropionate,their preparation and use |
Country Status (12)
Country | Link |
---|---|
US (1) | US4913892A (xx) |
EP (1) | EP0172672B1 (xx) |
KR (1) | KR880001237B1 (xx) |
AU (1) | AU566318B2 (xx) |
CA (1) | CA1274503A (xx) |
DE (1) | DE3561321D1 (xx) |
DK (1) | DK336485A (xx) |
HK (1) | HK58789A (xx) |
IE (1) | IE59086B1 (xx) |
IL (1) | IL75903A (xx) |
NO (1) | NO163899C (xx) |
NZ (1) | NZ212877A (xx) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR890000664B1 (ko) * | 1981-10-19 | 1989-03-22 | 바리 안소니 뉴우샘 | 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법 |
PT78973A (en) * | 1984-07-25 | 1984-08-01 | Joao Emerico Villax | New preparation process of the 9alpha-fluoro 17,21-acylates or hidroxilades in 17 and 21 chloro-corticosteroid |
GB8432063D0 (en) * | 1984-12-19 | 1985-01-30 | Riker Laboratories Inc | Physically modified steroids |
MX9203481A (es) * | 1990-10-18 | 1992-07-01 | Minnesota Mining & Mfg | Formulaciones. |
US7101534B1 (en) | 1991-12-18 | 2006-09-05 | 3M Innovative Properties Company | Suspension aerosol formulations |
MX9304585A (es) | 1992-07-31 | 1994-03-31 | Glaxo Group Ltd | Formulacion farmaceutica en aerosol, lata adecuada para liberar la formulacion e inhalador de dosis dosificada que comprende la lata. |
US5962445A (en) | 1996-05-09 | 1999-10-05 | Amrad Operations Pty Ltd. | Treatment of asthma and airway diseases |
GB0208742D0 (en) | 2002-04-17 | 2002-05-29 | Bradford Particle Design Ltd | Particulate materials |
ES2691033T3 (es) | 2007-02-11 | 2018-11-23 | Map Pharmaceuticals Inc. | Método de administración terapéutica de DHE para activar el alivio rápido de la migraña a la vez que se reduce al mínimo el perfil de los efectos secundarios |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4044126A (en) * | 1972-04-20 | 1977-08-23 | Allen & Hanburys Limited | Steroidal aerosol compositions and process for the preparation thereof |
ATE3774T1 (de) * | 1980-05-02 | 1983-06-15 | Schering Corporation | Beclomethason-ester-solvate, verfahren zu ihrer herstellung und herstellung einer formulierung. |
GB2107715B (en) * | 1981-10-19 | 1985-11-13 | Glaxo Group Ltd | Micronised beclomethasone dipropionate monohydrate and powder inhalation compositions containing it |
-
1985
- 1985-07-24 IE IE185285A patent/IE59086B1/en not_active IP Right Cessation
- 1985-07-24 AU AU45305/85A patent/AU566318B2/en not_active Ceased
- 1985-07-24 US US06/758,287 patent/US4913892A/en not_active Expired - Fee Related
- 1985-07-24 DK DK336485A patent/DK336485A/da not_active Application Discontinuation
- 1985-07-24 IL IL8575903A patent/IL75903A/xx not_active IP Right Cessation
- 1985-07-24 KR KR1019850005290A patent/KR880001237B1/ko not_active IP Right Cessation
- 1985-07-24 NO NO852948A patent/NO163899C/no unknown
- 1985-07-25 DE DE8585305303T patent/DE3561321D1/de not_active Expired
- 1985-07-25 CA CA000487542A patent/CA1274503A/en not_active Expired - Lifetime
- 1985-07-25 EP EP85305303A patent/EP0172672B1/en not_active Expired
- 1985-07-25 NZ NZ212877A patent/NZ212877A/en unknown
-
1989
- 1989-07-20 HK HK587/89A patent/HK58789A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO852948L (no) | 1986-01-27 |
AU4530585A (en) | 1986-01-30 |
EP0172672A1 (en) | 1986-02-26 |
HK58789A (en) | 1989-07-28 |
DE3561321D1 (en) | 1988-02-11 |
NZ212877A (en) | 1988-03-30 |
US4913892A (en) | 1990-04-03 |
DK336485A (da) | 1986-01-26 |
IE59086B1 (en) | 1994-01-12 |
CA1274503A (en) | 1990-09-25 |
NO163899B (no) | 1990-04-30 |
EP0172672B1 (en) | 1988-01-07 |
KR860001122A (ko) | 1986-02-22 |
DK336485D0 (da) | 1985-07-24 |
IL75903A0 (en) | 1985-12-31 |
AU566318B2 (en) | 1987-10-15 |
NO163899C (no) | 1990-08-08 |
KR880001237B1 (ko) | 1988-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3270153D1 (en) | Vacuum monitor for vacuum interrupter and use of the vacuum monitor | |
IL67517A (en) | Stabilized alpha-interferon formulations and their preparation | |
AU2902784A (en) | X-ray dispersive structures and method of manufacture | |
GB2099437B (en) | Urethane copolymers and the method of their preparation | |
EP0180719A3 (en) | The preparation of ethanol and higher alcohols from lower carbon number alcohols | |
GB2198071B (en) | Medical devices and methods for their manufacture | |
IL75903A (en) | Di-isopropyl ether solvates of beclomethasone 17,21-dipropionate,their preparation and use | |
JPS57183724A (en) | Medicinal composition and manufacture | |
IL74540A (en) | Glycerol ether phosphatides and their manufacture | |
EP0201537A4 (en) | NEW USE OF ANTI-NAUSEA AND ANTI-EMETICS AGENTS. | |
PT78049B (en) | Biologically active ketone derivative preparation and use | |
EP0446783A3 (en) | Procedure for the preparation of n-aryl substituted 2-aminoalkyl-2-hydroxyalkylamines and n-aryl substituted piperazines | |
JPS55154973A (en) | 1*3*77trialkylxanthine* its manufacture and medical composition | |
GB2152058B (en) | 17-ethynyl-6-fluoro steroids, their preparation and use | |
PL234346A1 (en) | Sliding composition and method of making the same | |
DE3277171D1 (en) | Pharmaceutical composition and the use of sn- or cr-protoporphyrin for the manufacture thereof | |
PT75613B (en) | Process for the preparation of carboxamid-thiol-carbamate deri-vatives and herbicide compositions thereof | |
ZA855620B (en) | Preparation and use of solvates of beclomethasone 17,21-dipropionate | |
DE3272452D1 (en) | Medicinal composition and method of making same | |
DE3566678D1 (en) | Methods of preparing 11 beta, 17 alpha, 20, 21-tetra-hydroxy steroids and corresponding 11 beta, 17 alpha, 21-trihydroxy-20-oxo steroids | |
IL66741A0 (en) | Cyclic keto-butyraldehydes,their preparation and their use in the preparation of cyclic diisocyanates | |
IL74022A (en) | Preparation of terpinen-4-ol and 1(7)-terpinen-4-ol | |
JPS5639269A (en) | Fixation and connection construction of oppositionnassembled form | |
DE3163316D1 (en) | Diacyloxyalkadienes and their preparation | |
AU2827884A (en) | Arylcycloalkyl ether derivatives their use and preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB | Patent renewed | ||
KB | Patent renewed | ||
EXP | Patent expired |